These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 25744045

  • 1. [Development of chronic myelogenous leukemia during treatment with TPO receptor agonist for ITP].
    Hattori H, Kuwayama M, Takamori H, Nishiura N, Karasuno T.
    Rinsho Ketsueki; 2014 Dec; 55(12):2429-32. PubMed ID: 25744045
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Eltrombopag--an oral thrombopoietin agonist.
    Sharma V, Randhawa H, Sharma A, Aggarwal S.
    Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):743-6. PubMed ID: 22913204
    [Abstract] [Full Text] [Related]

  • 5. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
    Aoki T, Harada Y, Matsubara E, Suzuki T, Oyama T, Kasai M, Uchida T, Ogura M.
    J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
    Kühne T, Imbach P.
    Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.
    Gudbrandsdottir S, Frederiksen H, Hasselbalch H.
    Platelets; 2012 Jul; 23(6):423-9. PubMed ID: 22185370
    [Abstract] [Full Text] [Related]

  • 11. Thrombopoetin receptor agonist therapy in thrombocytopenia: ITP and beyond.
    Taylor A, Westwood JP, Laskou F, McGuckin S, Scully M.
    Br J Haematol; 2017 May; 177(3):475-480. PubMed ID: 28295201
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura: A Case Series.
    Kowalczyk M, Rubinstein PG, Aboulafia DM.
    J Int Assoc Provid AIDS Care; 2015 May; 14(3):211-6. PubMed ID: 25504472
    [Abstract] [Full Text] [Related]

  • 15. Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpura.
    Zhang Y, Kolesar JM.
    Clin Ther; 2011 Nov; 33(11):1560-76. PubMed ID: 22054810
    [Abstract] [Full Text] [Related]

  • 16. Thrombopoietin receptor agonists shift the balance of Fcγ receptors toward inhibitory receptor IIb on monocytes in ITP.
    Liu XG, Liu S, Feng Q, Liu XN, Li GS, Sheng Z, Chen P, Liu Y, Wei Y, Dong XY, Qin P, Gao C, Ma C, Zhang L, Hou M, Peng J.
    Blood; 2016 Aug 11; 128(6):852-61. PubMed ID: 27281793
    [Abstract] [Full Text] [Related]

  • 17. Review article: second-generation thrombopoietin agents for treatment of chronic idiopathic thrombocytopenic purpura in adults.
    Lam MS.
    J Oncol Pharm Pract; 2010 Jun 11; 16(2):89-103. PubMed ID: 19525300
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
    Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L, Salama A, Jenkins JM, Roychowdhury D, Mayer B, Stone N, Arning M.
    Lancet; 2009 Feb 21; 373(9664):641-8. PubMed ID: 19231632
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.